LifeVac Becomes the First and Only FDA-Authorized Anti-Choking Device
Under the order, LifeVac is classified as a Class II medical device. The FDA defines this device type as one intended to be used, by application of suction, to resolve choking in victims experiencing complete airway obstruction, and to be used as a second-line treatment in an emergency situation after unsuccessful use of a basic life support (BLS) choking protocol.
The cleared indications state that LifeVac is a non-powered, non-invasive, single-use-only airway clearance device intended for adult and pediatric choking victims (at least 1 year of age), and may be administered by a lay person or medical professional (18 years or older) in settings including homes, nursing homes, restaurants, and schools.
FDA determined that Class II classification, together with general and special controls, provides reasonable assurance of the safety and effectiveness of the device for its intended use.
"As stated in the order, LifeVac is intended to be used after a BLS choking protocol fails," said
As a result of the order, LifeVac may immediately market the device as described in the De Novo request, subject to the general and special controls outlined by FDA.
About LifeVac LLC:
LifeVac is a company known for its lifesaving airway clearance device of the same name. Founded in 2012, it is based out of
Media Contact:
516-659-4122
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/lifevac-becomes-the-first-and-only-fda-authorized-anti-choking-device-302706244.html
SOURCE LifeVac
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Football Tournament Season Sparks Global Social Connection Surge as 3Fun Reports Growth Across Key Markets
- Academy Software Foundation Welcomes CIQ, Evercast, and Rochester Institute of Technology as New Members
- LEPAS L4 EV Set to Launch: Celebrating Football's Defining Moments with Elegant Performance
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share